Statins are a promising candidate adjunctive therapy for prevention or treatment of HIV-1 associated neurocognitive disorders (HAND)

被引:0
|
作者
Yadav, Anjana [1 ]
Kolson, Lorraine [2 ]
Betts, Michael [3 ]
Kolson, Dennis [2 ]
Collman, Ronald [1 ]
机构
[1] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurol, Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Microbiol, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P195
引用
收藏
页码:S91 / S92
页数:2
相关论文
共 50 条
  • [31] Time Estimation and Production in HIV-Associated Neurocognitive Disorders (HAND)
    Doyle, Katie L.
    Morgan, Erin E.
    Weber, Erica
    Woods, Steven Paul
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2015, 21 (02) : 175 - 181
  • [32] Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders
    Kristen A. McLaurin
    Rosemarie M. Booze
    Charles F. Mactutus
    [J]. Journal of NeuroVirology, 2018, 24 : 229 - 245
  • [33] Challenges to Neurotherapeutics Development for HIV-associated neurocognitive disorders (HAND)
    Steiner, Joseph
    Wang, Tongguang
    Choi, Elliot
    Nath, Avindra
    [J]. JOURNAL OF NEUROVIROLOGY, 2012, 18 : 106 - 106
  • [34] Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders
    Eggert, Dawn
    Dash, Prasanta K.
    Serradji, Nawal
    Dong, Chang-Zhi
    Clayette, Pascal
    Heymans, Francoise
    Dou, Huanyu
    Gorantla, Santhi
    Gelbard, Harris A.
    Poluektova, Larisa
    Gendelman, Howard E.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 213 (1-2) : 47 - 59
  • [35] Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
    McLaurin, Kristen A.
    Moran, Landhing M.
    Booze, Rosemarie M.
    Mactutus, Charles F.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2020, 15 (02) : 264 - 279
  • [36] Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
    Kristen A. McLaurin
    Landhing M. Moran
    Rosemarie M. Booze
    Charles F. Mactutus
    [J]. Journal of Neuroimmune Pharmacology, 2020, 15 : 264 - 279
  • [37] HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders
    Cotto, Bianca
    Natarajanseenivasan, Kalimuthusamy
    Langford, Dianne
    [J]. PROGRESS IN NEUROBIOLOGY, 2019, 181
  • [38] PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy
    Jaime H. Vera
    Basil Ridha
    Yvonne Gilleece
    Aliza Amlani
    Patrick Thorburn
    Sabina Dizdarevic
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 895 - 902
  • [39] PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy
    Vera, Jaime H.
    Ridha, Basil
    Gilleece, Yvonne
    Amlani, Aliza
    Thorburn, Patrick
    Dizdarevic, Sabina
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (05) : 895 - 902
  • [40] The HAND Database: a gateway to understanding the role of HIV in HIV-associated neurocognitive disorders
    Griffin, Tess Z.
    Kang, Weiliang
    Ma, Yongjie
    Zhang, Ming
    [J]. BMC MEDICAL GENOMICS, 2015, 8